Summary
Aptuit LLC (Aptuit) is a healthcare service provider that offers drug and clinical bioscience services. The company provides services including drug discovery, development and manufacturing support services. It provides drug design and discovery, API development and manufacture, solid state chemistry, sterile fill finish and formulation development, integrated drug discovery and drug development, clinical sciences, solid and oral dosage form development and manufacture and consulting services. Aptuit carries out project management to deliver the drug effectively. The company’s technology, Aptuit INDiGO helps in accelerating early drug candidates into clinic. It operates in the US, Scotland, India, England and Italy. Aptuit is headquartered in Greenwich, Connecticut, the US.
Aptuit LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Aptuit LLC, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Aptuit LLC, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Aptuit LLC, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Aptuit LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Aptuit LLC, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Aptuit LLC, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Bioversys and Aptuit Enter into Partnership 10
Aptuit Enters into Agreement with Massachusetts General Hospital 10
Chronos Therapeutics Partners with Aptuit 11
Aptuit Enters into Agreement with Chiesi Farmaceutici 12
Aptuit Enters into Agreement with Dimension Therapeutics 13
Icagen Partners with Aptuit 13
Asset Transactions 14
Catalent Pharma Completes Acquisition Of Clinical Trial Supplies Business From Aptuit For US$410 Million 14
Acquisition 15
Aptuit Acquires Kuecept 15
Aptuit Acquires Exquiron Biotech 16
Albany Molecular Research Acquires SSCI from Aptuit for USD36 Million 17
Albany Molecular Research Acquires Aptuit Glasgow from Aptuit for USD24 Million 18
Aptuit LLC - Key Competitors 20
Key Employees 21
Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23
List of Tables
Aptuit LLC, Pharmaceuticals & Healthcare, Key Facts 1
Aptuit LLC, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Aptuit LLC, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Aptuit LLC, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Aptuit LLC, Deals By Therapy Area, 2011 to YTD 2017 8
Aptuit LLC, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Bioversys and Aptuit Enter into Partnership 10
Aptuit Enters into Agreement with Massachusetts General Hospital 10
Chronos Therapeutics Partners with Aptuit 11
Aptuit Enters into Agreement with Chiesi Farmaceutici 12
Aptuit Enters into Agreement with Dimension Therapeutics 13
Icagen Partners with Aptuit 13
Catalent Pharma Completes Acquisition Of Clinical Trial Supplies Business From Aptuit For US$410 Million 14
Aptuit Acquires Kuecept 15
Aptuit Acquires Exquiron Biotech 16
Albany Molecular Research Acquires SSCI from Aptuit for USD36 Million 17
Albany Molecular Research Acquires Aptuit Glasgow from Aptuit for USD24 Million 18
Aptuit LLC, Key Competitors 20
Aptuit LLC, Key Employees 21
Aptuit LLC, Subsidiaries 22
List of Figures
Aptuit LLC, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1
Aptuit LLC, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1
Aptuit LLC, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1
Aptuit LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1
Aptuit LLC, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Aptuit LLC, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
Aptuit LLC, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Aptuit LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8